KOUNTOUPES DENHAM CARR & REID, LLC for GLENMARK PHARMACEUTICALS, INC., USA
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 18, 2019 | $50,000 | Replaced |
| 3rd Quarter - Amendment | Mar 29, 2021 | $50,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General education about the generic pharmaceutical industry.
Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MJ KENNY | Deputy Floor Director, Floor Assistant - Office of the Senate Democratic Whip; Legislative Aide, Legislative Correspondent - Senator Richard J. Durbin (D-IL) |
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
| MARY R "RANDI" REID | — |
Medicare/Medicaid MMM
Issues related to Medicaid CPI Penalty.
Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MJ KENNY | — |
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
Pharmacy PHA
General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals. Issues related to S.1895, the Lower Health Care Costs Act.
Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MJ KENNY | — |
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
| MARY R "RANDI" REID | — |
Copyright/Patent/Trademark CPT
Issues related to the abuses of the patent system, extensions of drug exclusivity, pay-for-delay, and the inter partes review (IPR) process, including H. R. 1499, the Protecting Consumer Access to Generic Drugs Ace of 2019, and H. R. 938, the BLOCKING Act of 2019.
Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MJ KENNY | — |
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
| MARY R "RANDI" REID | — |
| ROSE SULLIVAN (LISTED IN ERROR) | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.